Karl Cahill
Fondateur chez MOSS GENOMICS INC.
Fortune : 51 000 $ au 31/05/2024
Postes actifs de Karl Cahill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| MOSS GENOMICS INC. | Directeur/Membre du Conseil | 11/01/2021 | - |
| Directeur Général | 11/01/2021 | - | |
| Fondateur | 25/09/2018 | - |
Historique de carrière de Karl Cahill
Anciens postes connus de Karl Cahill
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Concordia Resource Corp.
 Concordia Resource Corp. Other Metals/MineralsNon-Energy Minerals Concordia Resource Corp. is a junior exploration company with an emphasis on developing mineral deposits in Africa and South America. The company has an extensive exploration portfolio in the resource-endowed regions of Burkina Faso, Gabon, and the Democratic Republic of Congo. In addition, it holds interests in the La Providencia silver mine located in the Puna district of northwestern Argentina and also holds interests in the Cerro Amarillo-Cajon Grande copper-gold-molybdenum property located in the Malargüe District of Argentina. The company was founded on February 7, 2000 and is headquartered in Vancouver, Canada. | Investor Relations Contact | 05/04/2011 | 16/08/2012 |
| Public Communications Contact | 25/08/2011 | 16/08/2012 | |
Raptor Pharmaceuticals Corp.
 Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Public Communications Contact | 15/04/2009 | 01/10/2009 |
| ABRASILVER RESOURCE CORP. | Investor Relations Contact | - | - |
Formation de Karl Cahill
| University of Westminster | Undergraduate Degree |
Statistiques
Internationale
| Canada | 3 |
| Etats-Unis | 2 |
| Royaume-Uni | 2 |
Opérationnelle
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Non-Energy Minerals | 3 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ABRASILVER RESOURCE CORP. | Non-Energy Minerals |
| Entreprise privées | 3 |
|---|---|
Raptor Pharmaceuticals Corp.
Raptor Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology The Group's principal activity is to research and development a novel drug and drug-targeting platform intended to initially treat a variety of brain disorders, neurodegenerative diseases, cancer and metabolic diseases through the proprietary use of a natural human protein known as the receptor-associated protein (RAP). The Group is in development stage. The Group acquired Convivia, Inc in 2007. | Health Technology |
Concordia Resource Corp.
Concordia Resource Corp. Other Metals/MineralsNon-Energy Minerals Concordia Resource Corp. is a junior exploration company with an emphasis on developing mineral deposits in Africa and South America. The company has an extensive exploration portfolio in the resource-endowed regions of Burkina Faso, Gabon, and the Democratic Republic of Congo. In addition, it holds interests in the La Providencia silver mine located in the Puna district of northwestern Argentina and also holds interests in the Cerro Amarillo-Cajon Grande copper-gold-molybdenum property located in the Malargüe District of Argentina. The company was founded on February 7, 2000 and is headquartered in Vancouver, Canada. | Non-Energy Minerals |
| Moss Genomics, Inc. |
- Bourse
- Insiders
- Karl Cahill
- Expérience
